IL177888A0 - X-ray contrast formulation comprising a mixture of iodinated monomer and dimer - Google Patents

X-ray contrast formulation comprising a mixture of iodinated monomer and dimer

Info

Publication number
IL177888A0
IL177888A0 IL177888A IL17788806A IL177888A0 IL 177888 A0 IL177888 A0 IL 177888A0 IL 177888 A IL177888 A IL 177888A IL 17788806 A IL17788806 A IL 17788806A IL 177888 A0 IL177888 A0 IL 177888A0
Authority
IL
Israel
Prior art keywords
mixture
dimer
ray contrast
triiodo
monomer
Prior art date
Application number
IL177888A
Other languages
English (en)
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of IL177888A0 publication Critical patent/IL177888A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL177888A 2004-03-11 2006-09-04 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer IL177888A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55224004P 2004-03-11 2004-03-11
PCT/US2005/008389 WO2005087272A2 (en) 2004-03-11 2005-03-11 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer

Publications (1)

Publication Number Publication Date
IL177888A0 true IL177888A0 (en) 2006-12-31

Family

ID=34964357

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177888A IL177888A0 (en) 2004-03-11 2006-09-04 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer

Country Status (12)

Country Link
US (1) US8679460B2 (enExample)
EP (2) EP1725268B1 (enExample)
JP (1) JP2007528424A (enExample)
KR (1) KR20070015517A (enExample)
CN (1) CN1938050A (enExample)
AT (1) ATE529135T1 (enExample)
AU (1) AU2005221716A1 (enExample)
CA (1) CA2559628A1 (enExample)
ES (1) ES2374633T3 (enExample)
IL (1) IL177888A0 (enExample)
NO (1) NO20064629L (enExample)
WO (1) WO2005087272A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8445725B2 (en) * 2008-01-14 2013-05-21 Mallinckrodt Llc Process for the preparation of iosimenol
US11219696B2 (en) 2008-12-19 2022-01-11 Nationwide Children's Hospital Delivery of polynucleotides using recombinant AAV9
US20110256068A1 (en) * 2009-01-09 2011-10-20 Wistand Lars-Goeran Contrast media compositions
BR112012023063A2 (pt) * 2010-03-23 2016-05-17 Ge Healthcare As processo para a preparação de uma composição para raio x, e, composição de diagnóstico para raio x
US20130039888A1 (en) 2011-06-08 2013-02-14 Nationwide Children's Hospital Inc. Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders
JP2013091701A (ja) 2011-10-25 2013-05-16 Dow Corning Toray Co Ltd 硬化性組成物
US9725716B2 (en) * 2011-12-06 2017-08-08 Ohio State Innovation Foundation and Research Institute at Nationwide Children's Hospital Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease
CA2862495A1 (en) 2012-01-11 2013-07-18 Ge Healthcare As X-ray imaging contrast media with low iodine concentration and x-ray imaging process
HK1206939A1 (en) * 2012-05-30 2016-01-22 Verrow Pharmaceuticals, Inc. Stabilized formulations containing iodinated contrast agents and cyclodextrins
EP2879719B1 (en) 2012-08-01 2018-07-04 Nationwide Children's Hospital Intrathecal delivery of recombinant adeno-associated virus 9
KR102151088B1 (ko) * 2018-07-10 2020-09-02 한국원자력연구원 소체와 연결된 실 모양의 구조물 가시화 조성물 및 이의 가시화 방법
CN112386712B (zh) * 2020-11-09 2022-08-30 张洪 分子探针及其制备方法和用途
CN119656340A (zh) * 2024-12-13 2025-03-21 福安药业集团宁波天衡制药有限公司 一种碘佛醇注射液及其制备方法
CN120899953B (zh) * 2025-10-13 2025-12-12 浙江迪安鉴识科技有限公司 一种尸体用血管造影剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511871A1 (fr) * 1981-08-28 1983-03-04 Guerbet Sa Procede pour augmenter la tolerance des produits opacifiants et produits opacifiants ainsi obtenus
US5698739A (en) 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
CA2124559A1 (en) * 1991-12-03 1993-06-10 Mills Thomas Kneller Nonionic x-ray contrast agents, compositions and methods
IT1256248B (it) 1992-12-24 1995-11-29 Bracco Spa Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
DE19627309C2 (de) * 1996-06-27 1999-07-29 Schering Ag Wäßrige injizierbare Formulierungen verwendbar als Kontrastmittel
US8518373B2 (en) * 2001-08-03 2013-08-27 Bracco Imaging Spa Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics
ITMI20011706A1 (it) 2001-08-03 2003-02-03 Bracco Imaging Spa Agenti di contrasto radiografici ionici e non ionici, utilizzabili per l'indagine diagnostica combinata tramite raggi-x e risonanza magnetic
US7250153B2 (en) * 2002-12-12 2007-07-31 Biophysica Research, Inc. Contrast media formulations having improved biological tolerance

Also Published As

Publication number Publication date
JP2007528424A (ja) 2007-10-11
AU2005221716A1 (en) 2005-09-22
CA2559628A1 (en) 2005-09-22
EP2253332A3 (en) 2011-03-23
US20080317675A1 (en) 2008-12-25
EP1725268B1 (en) 2011-10-19
EP1725268A2 (en) 2006-11-29
EP2253332A2 (en) 2010-11-24
US8679460B2 (en) 2014-03-25
ATE529135T1 (de) 2011-11-15
CN1938050A (zh) 2007-03-28
ES2374633T3 (es) 2012-02-20
KR20070015517A (ko) 2007-02-05
NO20064629L (no) 2006-11-28
EP2253332B1 (en) 2012-10-10
WO2005087272A2 (en) 2005-09-22
WO2005087272A3 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
IL177888A0 (en) X-ray contrast formulation comprising a mixture of iodinated monomer and dimer
TW200738666A (en) Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
MX2008000141A (es) Moduladores de lxr basados en imidazol.
CO6280399A2 (es) Peptidil nitrilos y uso de los mismos como inhibidores de peptidil peptidasa i
GEP20125506B (en) Glucagon receptor antagonist compounds, compositions containing such compounds and use
MX2007013065A (es) Derivados de dihidrobenzofurano y usos de los mismos.
CL2008001775A1 (es) Compuestos derivados de 2-amino-7-alquinil-[1,8]naftiridona, inhibidores de vegfr-3; composición farmacéutica; combinación farmacéutica; procedimiento de preparación; compuesto intermediario; y uso en el tratamiento del cáncer.
PL396711A1 (pl) Koniugaty polimerów z cytokinami, chemokinami, czynnikami wzrostu, hormonami polipeptydowymi i ich antagonistami, kompozycja farmaceutyczna i sposób zapobiegania, diagnozowania lub leczenia
DE69318727D1 (de) Wässerige einspritzbare Zusammensetzungen verwendbar zur Radiodiagnose enthaltenden jodierten aromatischen Verbindungen zur Verwendung als Röntgenkontrastmittel
UA95766C2 (ru) Производные терфенила для лечения болезни альцгеймера
PA8556901A1 (es) Nuevos derivados de piperazina
TW200719886A (en) Dihydrobenzofuran derivatives and uses thereof
ECSP077262A (es) Composicion antihistaminica
DE602007012208D1 (de) Kontrastmittel
DE60230424D1 (en) Arylsulfonyl-derivate mit 5-ht 6-rezeptor-affinität
IL198995A0 (en) Novel compound having affinity for amyloid
IL194889A0 (en) Compound having affinity to amyloid
MX2009008324A (es) Compuestos 6´-sustituidos que tienen afinidad con el receptor de 5-hidroxitriptamina-6.
ATE423546T1 (de) Triterpenhaltiger oleogelbildner, triterpenhaltiges oleogel und verfahren zur herstellung eines triterpenhaltigen oleogels
WO2007066336A3 (en) Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
EP3502226A1 (en) Gel composition
MXPA04005313A (es) Derivados de aminotetralin como antagonistas del receptor muscarinico.
BRPI0701285A (pt) material dental formador de hidróxi-apatita com efeito bioativo
GB0425548D0 (en) Radiolabelled ligands
TNSN07241A1 (en) Substituted pyrroles, compositions containing same, method for making same and use thereof